Cage Bio
PrivateLast Round
VC Round
Apr 29, 2025
Total Funding Raised
$27.71M
Company Overview
Cage Bio is a biotechnology company that develops novel dermatological and immunological therapies using a proprietary deep eutectic ionic liquid platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cage Bio Comparables
Compare Cage Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theravie Pharma, Inc. | 82% | |
| Yarrow Bioscience, Inc. | 77% | |
| Guardian Therapeutics | 77% |
For institutional investors. Book with your work email.
Cage Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 29, 2025 | ||||
| Series A Extension | Oct 27, 2021 | ||||
| Series A | Feb 16, 2021 | ||||
| Seed | Jul 3, 2019 |
For institutional investors. Book with your work email.
Cage Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Propel(x) | Series A |
| AG Collective Capital | Series A Extension, Series A |
| Johnson & Johnson Innovation - JLABS | Series A Extension |
| Cowtown Angels | Series A Extension, Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2025
Initiated double-blind trial for vitiligo therapy CGB-600.
- Oct 27, 2021
$15M raised from AG Collective Capital and others.
For institutional investors. Book with your work email.
Cage Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cage Bio's valuation, stock price, and market status.
Is Cage Bio a public or private company?
Cage Bio is a private company.
What is the current stock price of Cage Bio?
Cage Bio is a private company, so its shares have no public market price. Caplight tracks Cage Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cage Bio worth (valuation)?
Valuation information for Cage Bio is not publicly available.
Can I buy Cage Bio stock?
Cage Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cage Bio's last funding round?
Cage Bio's most recent funding round was VC Round on April 29, 2025.
Who are the main investors in Cage Bio?
Key investors in Cage Bio include Propel(x), AG Collective Capital, Johnson & Johnson Innovation - JLABS, Cowtown Angels.
Will Cage Bio IPO soon?
No public IPO plans have been announced for Cage Bio.
How can I track Cage Bio secondary market activity?
Caplight tracks bids, offers, and trades in Cage Bio's shares on secondary markets.